XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Collaboration Agreements,License Agreement and Revenues - Roll-forward of Related Contract Liabilities (Detail)
$ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
Contract with Customer Liability [Line Items]  
Balance at December 31, 2020 $ (2,147)
Balance at December 31, 2021 (58,909)
AstraZeneca Agreements [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2020 (137,338)
Additions (69,746)
Balance at December 31, 2021 (171,516)
Milestone payment received 35,568
Product [Member] | Direct Sales [Member] | Contract Liabilities [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2020 (15,137)
Additions (1,371)
Deduction 13,645
Currency Translation and Other (313)
Balance at December 31, 2021 (3,176)
Drug Product Revenue [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2020 (5,984)
Additions (83,019)
Balance at December 31, 2021 (39,036)
Milestone payment received 179
Balance Presented Net Against Contract Asset 49,788
Drug Product Revenue [Member] | AstraZeneca Agreements [Member] | U.S. [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2020 0
Additions (11,171)
Balance at December 31, 2021 (11,171)
Milestone payment received 0
Balance Presented Net Against Contract Asset 0
Drug Product Revenue [Member] | Astellas Agreement | Japan [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2020 0
Additions (1,974)
Balance at December 31, 2021 (1,974)
Milestone payment received 0
Balance Presented Net Against Contract Asset 0
Drug Product Revenue [Member] | Astellas Agreement | Europe [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2020 (5,984)
Additions (69,874)
Balance at December 31, 2021 (25,891)
Milestone payment received 179
Balance Presented Net Against Contract Asset $ 49,788